Charter Oak Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61M | Buy |
8,671
+134
| +2% | +$24.9K | 0.14% | 52 |
|
|
2025
Q1 | $1.79M | Buy |
8,537
+78
| +0.9% | +$16.3K | 0.16% | 45 |
|
|
2024
Q4 | $1.5M | Sell |
8,459
-333
| -4% | -$59.2K | 0.14% | 54 |
|
|
2024
Q3 | $1.74M | Buy |
8,792
+712
| +9% | +$141K | 0.16% | 48 |
|
|
2024
Q2 | $1.39M | Sell |
8,080
-148
| -2% | -$25.4K | 0.14% | 57 |
|
|
2024
Q1 | $1.5M | Buy |
8,228
+357
| +5% | +$65K | 0.16% | 53 |
|
|
2023
Q4 | $1.22M | Buy |
7,871
+356
| +5% | +$55.2K | 0.14% | 57 |
|
|
2023
Q3 | $1.12M | Sell |
7,515
-9
| -0.1% | -$1.34K | 0.15% | 58 |
|
|
2023
Q2 | $1.01M | Buy |
7,524
+12
| +0.2% | +$1.62K | 0.13% | 67 |
|
|
2023
Q1 | $1.2M | Buy |
7,512
+8
| +0.1% | +$1.28K | 0.17% | 58 |
|
|
2022
Q4 | $1.21M | Buy |
7,504
+11
| +0.1% | +$1.78K | 0.18% | 59 |
|
|
2022
Q3 | $1.01M | Buy |
7,493
+163
| +2% | +$21.9K | 0.16% | 60 |
|
|
2022
Q2 | $1.12M | Sell |
7,330
-38
| -0.5% | -$5.82K | 0.15% | 62 |
|
|
2022
Q1 | $1.19M | Buy |
7,368
+841
| +13% | +$136K | 0.15% | 63 |
|
|
2021
Q4 | $884K | Buy |
6,527
+73
| +1% | +$9.89K | 0.1% | 83 |
|
|
2021
Q3 | $696K | Buy |
6,454
+32
| +0.5% | +$3.45K | 0.09% | 92 |
|
|
2021
Q2 | $723K | Buy |
6,422
+198
| +3% | +$22.3K | 0.09% | 91 |
|
|
2021
Q1 | $674K | Buy |
6,224
+97
| +2% | +$10.5K | 0.09% | 94 |
|
|
2020
Q4 | $657K | Buy |
+6,127
| New | +$657K | 0.1% | 92 |
|